TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 403,003 | 460,633 | 323,970 |
Financial expenses | 4,569 | 198 | 1,823 |
Earnings before taxes | 4,308 | 11,577 | 5,343 |
EBITDA | 7,130 | 11,678 | 5,226 |
Total assets | 190,219 | 161,095 | 214,909 |
Current assets | 189,966 | 160,847 | 214,293 |
Current liabilities | 130,799 | 104,738 | 167,518 |
Equity capital | 45,420 | 42,357 | 33,391 |
- share capital | 100 | 100 | 100 |
Employees (average) | 21 | 19 | 18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 23.9% | 26.3% | 15.5% |
Turnover per employee | 19,191 | 24,244 | 17,998 |
Profit as a percentage of turnover | 1.1% | 2.5% | 1.6% |
Return on assets (ROA) | 4.7% | 7.3% | 3.3% |
Current ratio | 145.2% | 153.6% | 127.9% |
Return on equity (ROE) | 9.5% | 27.3% | 16.0% |
Change turnover | -57,630 | 136,663 | 4,683 |
Change turnover % | -13% | 42% | 1% |
Chg. No. of employees | 2 | 1 | 2 |
Chg. No. of employees % | 11% | 6% | 13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.